Introduction Autologous chondrocyte implantation (ACI) is a biomedical treatment that repairs cartilage injury in the knee joint, which has been shown to reduce pain and facilitate mobility recovery ( Typically, ACI involves harvesting cartilage, isolating chondrocytes, expanding cells in vitro , and re-implanting over an articular cartilage defect
Start with The Lancet s results
The resulting crude peptide is then cleaved from the resin, deprotected, and subjected to multistep purification (chromatography, crystallization) to remove byproducts, protecting groups, and residual solvent ( [20] )
Cannot redeclare control with same name "grid_3_qv_quantitiy_border_color"
The incidence of gastrointestinal adverse events was 72.5% with CagriSema versus 34.4% with placebo, predominantly transient and mild to moderate in severity